Free Review Articles on Endocannabinoid                                 Metatextbook

Freie Reviews über Endocannabinoid                                 Look here for Journal Homepages

  • Endocannabinoid
  • Phobia (Neurophysiology)
  • Reward (Neurophysiology)
  • Receptor (PPAR)
  • Steatohepatosis
  • Fibrosis
  • Cyclooxygenases
  • 2 Arachidonoylglycerol
  • Arachidonylethanolamide
  • COX2
  • Glyceryl prostaglandins
  • Cannabis
  • Antiinflammatory compounds
  • Neuron (BASKET)
  • PAF
  • Arachidonoyldiacylcylglycerol
  • Docosahexaenoic acid
  • Ischemia reperfusion
  • Receptor (Cannabinoid)
  • JWH133
  • Natural products
  • Neuroprotective agents
  • Microdialysis
  • Glaucoma
  • Bimatoprost
  • Prostamid
  • Anandamide
  • Prefrontal cortex
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12008The endocannabinoid system: an osteopathic perspective.



    		+-nlJ Am Osteopath Assoc 108(10):586-600 (2008)
    22007The endocannabinoid system as a novel approach for managing obesity.



    		+-nlJ Am Osteopath Assoc 107(4 Suppl 2):S12-20 (2007)
    32005Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.



    		+-nlAlcohol Alcohol 40(1):25-34 (2005)
    42005The endocannabinoid system: physiology and pharmacology.



    		+-nlAlcohol Alcohol 40(1):2-14 (2005)
    52005Role of the endocannabinoid system in the development of tolerance to alcohol.



    		+-nlAlcohol Alcohol 40(1):15-24 (2005)
    62007Modulation of fear and anxiety by the endogenous cannabinoid system.



    		+-nlCNS Spectr 12(3):211-20 (2007)
    72007Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.



    		+-nlCurr Neuropharmacol 5(2):81-97 (2007)
    82009The endocannabinoid system as a target for the treatment of motor dysfunction.



    		+-nlBr J Pharmacol 156(7):1029-40 (2009)
    92009Emerging strategies for exploiting cannabinoid receptor agonists as medicines.



    		+-nlBr J Pharmacol 156(3):397-411 (2009)
    102008The endocannabinoid system in brain reward processes.



    		+-nlBr J Pharmacol 154(2):369-83 (2008)
    112008CB2 receptors in the brain: role in central immune function.



    		+-nlBr J Pharmacol 153(2):240-51 (2008)
    122008Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.



    		+-nlBr J Pharmacol 153(2):252-62 (2008)
    132008Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.



    		+-nlBr J Pharmacol 153(2):319-34 (2008)
    142008The peripheral cannabinoid receptor knockout mice: an update.



    		+-nlBr J Pharmacol 153(2):309-18 (2008)
    152008Cannabinoid CB2 receptors in human brain inflammation.



    		+-nlBr J Pharmacol 153(2):277-85 (2008)
    162008Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor.



    		+-nlBr J Pharmacol 153(2):271-6 (2008)
    172008Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.



    		+-nlBr J Pharmacol 153(2):226-39 (2008)
    182008Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.



    		+-nlBr J Pharmacol 153(2):263-70 (2008)
    192008CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.



    		+-nlBr J Pharmacol 153(2):216-25 (2008)
    202008The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.



    		+-nlBr J Pharmacol 153(2):199-215 (2008)
    212008CB2 receptors in reproduction.



    		+-nlBr J Pharmacol 153(2):189-98 (2008)
    222007Novel cannabinoid receptors.



    		+-nlBr J Pharmacol 152(5):567-75 (2007)
    232007Cannabinoid control of neuroinflammation related to multiple sclerosis.



    		+-nlBr J Pharmacol 152(5):649-54 (2007)
    242007The complications of promiscuity: endocannabinoid action and metabolism.



    		+-nlBr J Pharmacol 152(5):602-23 (2007)
    252007Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.



    		+-nlBr J Pharmacol 152(5):633-48 (2007)
    262007Endocannabinoids and the gastrointestinal tract: what are the key questions?



    		+-nlBr J Pharmacol 152(5):663-70 (2007)
    272007Endocannabinoids and the haematological system.



    		+-nlBr J Pharmacol 152(5):671-5 (2007)
    282007Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.



    		+-nlBr J Pharmacol 152(5):576-82 (2007)
    292007Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.



    		+-nlBr J Pharmacol 152(5):624-32 (2007)
    302007The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.



    		+-nlBr J Pharmacol 152(5):594-601 (2007)
    312007Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.



    		+-nlBr J Pharmacol 151(4):427-40 (2007)
    322005The expanding field of cannabimimetic and related lipid mediators.



    		+-nlBr J Pharmacol 144(4):459-65 (2005)
    332004Efficacy in CB1 receptor-mediated signal transduction.



    		+-nlBr J Pharmacol 142(8):1209-18 (2004)
    342004The complexities of the cardiovascular actions of cannabinoids.



    		+-nlBr J Pharmacol 142(1):20-6 (2004)
    352004Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).



    		+-nlBr J Pharmacol 142(1):9-19 (2004)
    362004Involvement of cannabinoid receptors in gut motility and visceral perception.



    		+-nlBr J Pharmacol 141(8):1335-45 (2004)
    372004Cannabinoids and neuroinflammation.



    		+-nlBr J Pharmacol 141(5):775-85 (2004)
    382004The endocannabinoid system: a general view and latest additions.



    		+-nlBr J Pharmacol 141(5):765-74 (2004)
    392003Emerging roles for endocannabinoids in long-term synaptic plasticity.



    		+-nlBr J Pharmacol 140(5):781-9 (2003)
    402003Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?



    		+-nlBr J Pharmacol 138(7):1183-4 (2003)
    412001Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.



    		+-nlJ Pharmacol Exp Ther 298(1):7-14 (2001)
    422000Endocannabinoids and vascular function.



    		+-nlJ Pharmacol Exp Ther 294(1):27-32 (2000)
    432006The endocannabinoid system as an emerging target of pharmacotherapy.



    		+-nlPharmacol Rev 58(3):389-462 (2006)
    442003The cannabinoid system and immune modulation.



    		+-nlJ Leukoc Biol 74(4):486-96 (2003)
    452007Cannabinoids: a new group of agonists of PPARs.



    		+-nlPPAR Res 2007(-):23513 (2007)
    462005Review article: endocannabinoids and their receptors in the enteric nervous system.



    		+-nlAliment Pharmacol Ther 22(8):667-83 (2005)
    472009Endocannabinoid-mediated control of synaptic transmission.



    		+-nlPhysiol Rev 89(1):309-80 (2009)
    482003Role of endogenous cannabinoids in synaptic signaling.



    		+-nlPhysiol Rev 83(3):1017-66 (2003)
    492006The emerging role of the endocannabinoid system in endocrine regulation and energy balance.



    		+-nlEndocr Rev 27(1):73-100 (2006)
    502005Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.



    		+-nlExp Biol Med (Maywood) 230(4):225-34 (2005)
    512005Neurotransmission: emerging roles of endocannabinoids.



    		+-nlCurr Biol 15(14):R549-51 (2005)
    522007Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients.



    		+-nlDiabetes Metab 33(2):85-95 (2007)
    532007Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system.



    		+-nlDiabetes Metab 33(2):97-107 (2007)
    542008Endocannabinoids in endocrine and related tumours.



    		+-nlEndocr Relat Cancer 15(2):391-408 (2008)
    552009Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists.



    		+-nlEur J Endocrinol 161(5):655-62 (2009)
    562001Cannabinoids and the gastrointestinal tract.



    		+-nlGut 48(6):859-67 (2001)
    572008Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.



    		+-nlHypertension 52(4):601-7 (2008)
    582010Role of cannabinoids in the development of fatty liver (steatosis).



    		+-nlAAPS J 12(2):233-7 (2010)
    592009Cannabinoids, endocannabinoids, and related analogs in inflammation.



    		+-nlAAPS J 11(1):109-19 (2009)
    602005Further advances in the synthesis of endocannabinoid-related ligands.



    		+-nlAAPS J 7(2):E496-502 (2005)
    612005The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.



    		+-nlAAPS J 7(3):E625-54 (2005)
    622008Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.



    		+-nlAm J Physiol Gastrointest Liver Physiol 294(1):G9-G12 (2008)
    632008Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.



    		+-nlAm J Physiol Gastrointest Liver Physiol 294(2):G357-62 (2008)
    642008Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases.



    		+-nlAm J Physiol Gastrointest Liver Physiol 294(4):G850-4 (2008)
    652008Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.



    		+-nlAm J Physiol Heart Circ Physiol 294(3):H1133-4 (2008) Pacher P
    662008Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids.



    		+-nlJ Biol Chem 283(13):8065-9 (2008)
    672002Cannabinoids on the brain.



    		+-nlScientificWorldJournal 2(-):632-48 (2002)
    682011Cannabinoids and innate immunity: taking a toll on neuroinflammation.



    		+-nlScientificWorldJournal 11(-):855-65 (2011)
    692003Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor.



    		+-nlJ Lipid Res 44(12):2221-33 (2003)
    702008Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.



    		+-nlEndocr Metab Immune Disord Drug Targets 8(3):159-72 (2008)
    712006Signaling pathways involved in the cardioprotective effects of cannabinoids.



    		+-nlJ Pharmacol Sci 102(2):155-66 (2006)
    722010Endocannabinoid signalling: has it got rhythm?



    		+-nlBr J Pharmacol 160(3):530-43 (2010) Vaughn LK
    732010Phytocannabinoids beyond the Cannabis plant - do they exist?



    		+-nlBr J Pharmacol 160(3):523-9 (2010) Gertsch J
    742010The endocannabinoid system as a target for the treatment of neurodegenerative disease.



    		+-nlBr J Pharmacol 160(3):480-98 (2010) Scotter EL
    752010CB2: a cannabinoid receptor with an identity crisis.



    		+-nlBr J Pharmacol 160(3):467-79 (2010) Atwood BK
    762010Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.



    		+-nlBr J Pharmacol 160(3):423-42 (2010) Buczynski MW
    772008Prostamides (prostaglandin-ethanolamides) and their pharmacology.



    		+-nlBr J Pharmacol 153(3):410-9 (2008)
    782008Cannabinoids for cancer treatment: progress and promise.



    		+-nlCancer Res 68(2):339-42 (2008)
    792006Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome.



    		+-nlMedGenMed 8(4):7 (2006)
    802007Serotonin, the prefrontal cortex, and the antidepressant-like effect of cannabinoids.



    		+-nlJ Neurosci 27(49):13369-70 (2007)
    812006The endocannabinoid system: a new perspective for cardiometabolic risk control.



    		+-nlArq Bras Cardiol 87(4):548-58 (2006)
    822008Signaling via CNS cannabinoid receptors.



    		+-nlMol Cell Endocrinol 286(1-2 Suppl 1):S60-5 (2008)
    832008Aspects of endocannabinoid signaling in periimplantation biology.



    		+-nlMol Cell Endocrinol 286(1-2 Suppl 1):S3-11 (2008)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.